{"filing":{"accession_number":"0001663577-26-000218","cik":"0001133818","ticker":"BPTH","company_name":"BIO-PATH HOLDINGS, INC.","form":"8-K","filing_date":"2026-07-16","report_date":null,"primary_document":"bpth_8k071626.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1133818/000166357726000218/bpth_8k071626.htm"},"events":[{"id":18361,"run_id":16504,"accession_number":"0001663577-26-000218","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"Bio-Path Holdings completed two unregistered sales of common shares under a qualified Tier 1 Regulation A offering on April 30 and May 13, 2026, totaling 955,300 shares and approximately $28,659 in net proceeds, with the capability to raise an additional $571,341 indicating ongoing dilutive financing activity.","company_name":"BIO-PATH HOLDINGS, INC.","ticker":"BPTH","filing_date":"2026-07-16","form":"8-K","submitted_at":null,"items":[{"id":17149,"accession_number":"0001663577-26-000218","item_number":"3.02","item_title":"Unregistered Sales of Equity","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses two unregistered sales of common shares under a qualified Tier 1 Regulation A offering (April 30 and May 13, 2026), totaling 955,300 shares and approximately $28,659 in net proceeds. Regulation A offerings are a form of equity capital raising that dilutes existing shareholders. The disclosure of the capability to raise an additional $571,341 indicates ongoing dilutive financing activity material to investors assessing the company's capital structure and shareholder equity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T17:57:48.179834+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":18362,"run_id":16504,"accession_number":"0001663577-26-000218","anchor_item_number":"5.03","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"The company's Board and Control Shareholder approved on July 14, 2026 the creation of a new Series B Preferred stock class with 5 million authorized shares, each convertible into 1,000 common shares, representing a material amendment to the articles of incorporation with significant potential dilution to common shareholders.","company_name":"BIO-PATH HOLDINGS, INC.","ticker":"BPTH","filing_date":"2026-07-16","form":"8-K","submitted_at":null,"items":[{"id":17150,"accession_number":"0001663577-26-000218","item_number":"5.03","item_title":"Amendments to Articles of Incorporation","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses creation of a new Series B Preferred stock class with 5 million authorized shares, each convertible into 1,000 common shares, approved by the Board and Control Shareholder on July 14, 2026. While this is a capital structure amendment (Item 5.03), the conversion ratio (1:1000) and authorization size suggest potential for significant dilution to common shareholders. This is a governance/capital structure event that does not fit the specific dilutive_issuance category (which typically covers actual sales of securities) but represents a material amendment to the articles of incorporation affecting shareholder rights and potential dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T17:57:48.179834+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17149,"accession_number":"0001663577-26-000218","item_number":"3.02","item_title":"Unregistered Sales of Equity","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses two unregistered sales of common shares under a qualified Tier 1 Regulation A offering (April 30 and May 13, 2026), totaling 955,300 shares and approximately $28,659 in net proceeds. Regulation A offerings are a form of equity capital raising that dilutes existing shareholders. The disclosure of the capability to raise an additional $571,341 indicates ongoing dilutive financing activity material to investors assessing the company's capital structure and shareholder equity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T17:57:48.179834+00:00","company_name":"BIO-PATH HOLDINGS, INC.","ticker":"BPTH","filing_date":"2026-07-16"},{"id":17150,"accession_number":"0001663577-26-000218","item_number":"5.03","item_title":"Amendments to Articles of Incorporation","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses creation of a new Series B Preferred stock class with 5 million authorized shares, each convertible into 1,000 common shares, approved by the Board and Control Shareholder on July 14, 2026. While this is a capital structure amendment (Item 5.03), the conversion ratio (1:1000) and authorization size suggest potential for significant dilution to common shareholders. This is a governance/capital structure event that does not fit the specific dilutive_issuance category (which typically covers actual sales of securities) but represents a material amendment to the articles of incorporation affecting shareholder rights and potential dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T17:57:48.179834+00:00","company_name":"BIO-PATH HOLDINGS, INC.","ticker":"BPTH","filing_date":"2026-07-16"},{"id":17151,"accession_number":"0001663577-26-000218","item_number":"7.1","item_title":"Regulation FD Disclosure","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The disclosure describes a broad strategic turnaround involving multiple operational initiatives: restarting/assessing drug trials, potential partnerships or IP licensing, blockchain technology exploration, capital raising, and strategic acquisitions outside biotech. This is a material operational and strategic pivot that does not fit a single named category (not M\u0026A completion, not a specific workforce action, not a single product milestone), making operational_other the most appropriate classification. The language \"strategic turnaround\" and enumeration of multiple business pivots signal material strategic repositioning.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T17:57:48.179834+00:00","company_name":"BIO-PATH HOLDINGS, INC.","ticker":"BPTH","filing_date":"2026-07-16"},{"id":17152,"accession_number":"0001663577-26-000218","item_number":"8.1","item_title":"Other Events.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"This Item 8.1 disclosure encompasses multiple material events spanning June–July 2026: (1) restart of Phase 2 AML trials at MD Anderson pending payment of ~$355K in arrears; (2) launch of a crypto treasury strategy with Coinbase allocating up to 50% of capital to digital assets; (3) engagement of Farrington Capital to identify strategic investors/buyers for biotech IP; (4) acquisition of majority stake in Himalaya Technologies (crypto social platform); (5) issuance of preferred shares to CEO for software IP; (6) termination of HMLA's strategic agreement and share cancellation; and (7) appointment of altFINS CEO to Advisory Board with equity grants and a planned cross-investment LOI. The filing mixes operational (trial restart, strategic advisory), financial (capital allocation to crypto, equity issuances), and governance (board appointment) events. No single event type cleanly encompasses this heterogeneous disclosure; the domain itself—spanning biotech operations, crypto treasury, M\u0026A-adjacent activity, and governance—is too diverse to fit a specific category, warranting `other_material`.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T17:57:48.179834+00:00","company_name":"BIO-PATH HOLDINGS, INC.","ticker":"BPTH","filing_date":"2026-07-16"}]}